JP2023500654A5 - - Google Patents
Info
- Publication number
- JP2023500654A5 JP2023500654A5 JP2022525323A JP2022525323A JP2023500654A5 JP 2023500654 A5 JP2023500654 A5 JP 2023500654A5 JP 2022525323 A JP2022525323 A JP 2022525323A JP 2022525323 A JP2022525323 A JP 2022525323A JP 2023500654 A5 JP2023500654 A5 JP 2023500654A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- composition
- composition according
- terlipressin
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962928152P | 2019-10-30 | 2019-10-30 | |
| US62/928,152 | 2019-10-30 | ||
| PCT/IB2020/060185 WO2021084483A1 (en) | 2019-10-30 | 2020-10-29 | Method of treating patients with hepatorenal syndrome type 1 and low mean arterial pressure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023500654A JP2023500654A (ja) | 2023-01-10 |
| JP2023500654A5 true JP2023500654A5 (https=) | 2023-11-07 |
Family
ID=73060034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525323A Pending JP2023500654A (ja) | 2019-10-30 | 2020-10-29 | １型肝腎症候群及び低い平均動脈圧を有する患者を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210128676A1 (https=) |
| EP (1) | EP4051310A1 (https=) |
| JP (1) | JP2023500654A (https=) |
| KR (1) | KR20220092868A (https=) |
| CN (1) | CN114980914A (https=) |
| AU (1) | AU2020373408A1 (https=) |
| BR (1) | BR112022006329A2 (https=) |
| CA (1) | CA3159575A1 (https=) |
| MX (1) | MX2022004157A (https=) |
| WO (1) | WO2021084483A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240019089A (ko) * | 2021-06-07 | 2024-02-14 | 말린크로트 파마슈티칼스 아일랜드 리미티드 | 간신장 증후군 1형 환자의 치료 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015203036A1 (en) * | 2010-07-14 | 2015-07-02 | Cumberland Emerging Technologies, Inc | Methods of Treating Hepatorenal Syndrom and Hepatic Encephalopathy with Thromboxane-A2 Receptor Antagonists |
| US10335452B2 (en) * | 2014-10-24 | 2019-07-02 | Mallinckrodt Hospital Products IP Limited | Method of treating patients with hepatorenal syndrome type 1 |
-
2020
- 2020-10-29 EP EP20801033.0A patent/EP4051310A1/en not_active Withdrawn
- 2020-10-29 AU AU2020373408A patent/AU2020373408A1/en not_active Abandoned
- 2020-10-29 JP JP2022525323A patent/JP2023500654A/ja active Pending
- 2020-10-29 CN CN202080073336.4A patent/CN114980914A/zh active Pending
- 2020-10-29 BR BR112022006329A patent/BR112022006329A2/pt not_active Application Discontinuation
- 2020-10-29 US US17/083,409 patent/US20210128676A1/en not_active Abandoned
- 2020-10-29 MX MX2022004157A patent/MX2022004157A/es unknown
- 2020-10-29 CA CA3159575A patent/CA3159575A1/en active Pending
- 2020-10-29 KR KR1020227013054A patent/KR20220092868A/ko active Pending
- 2020-10-29 WO PCT/IB2020/060185 patent/WO2021084483A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Luca et al. | Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis | |
| Sever et al. | The benefits of continuous ultrafiltration in pediatric cardiac surgery | |
| Gimson et al. | Earlier charcoal haemoperfusion in fulminant hepatic failure | |
| Wilcken et al. | Evidence for intravenous dipyridamole (Persantin) producing a “coronary steal” effect in the ischaemic myocardium | |
| JP2011520918A5 (https=) | ||
| SU1183112A1 (ru) | Способ лечени острой ишемии миокарда | |
| Cruz et al. | Intradialytic hypotension: Is midodrine beneficial in symptomatic hemodialysis patients? | |
| JP2023500654A5 (https=) | ||
| Bracht et al. | Cyclosporine A and control of vascular tone in the human forearm: influence of post-transplant hypertension | |
| Gorlin et al. | Cardiac glycosides in the treatment of cardiogenic shock | |
| US5906974A (en) | Hemoglobin therapy in hemodialysis | |
| Seltzer et al. | Decrease in arterial pressure following heparin injection prior to cardiopulmonary bypass | |
| JP2006502231A5 (https=) | ||
| Kim et al. | Circuit start during continuous renal replacement therapy in vasopressor-dependent patients: the impact of a slow blood flow protocol | |
| KORNS et al. | Benzedrine and paredrine in the treatment of orthostatic hypotension, with supplementary case report | |
| Niquille et al. | Reversal of intraoperative myocardial ischemia with a hemoglobin-based oxygen carrier | |
| US6355682B1 (en) | Treatment of acute renal failure by administration of N-acetylcysteine | |
| MILLS et al. | Treatment of Shock With Sympathicomimetic Drugs: Use of Metaraminol and Comparison With Other Vasopressor Agents | |
| Nagai et al. | Cardiac rescue of an infant with fulminant myocarditis using extracorporeal membrane oxygenation | |
| JP2023500654A (ja) | １型肝腎症候群及び低い平均動脈圧を有する患者を治療する方法 | |
| MURPHY et al. | Halothane and blood transfusion for phaeochromocytoma: a case report | |
| Kaisbain et al. | Verapamil-Induced Hypotension in End-Stage Renal Disease: the Role of Calcium Gluconate | |
| Halank et al. | Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension | |
| Fagan et al. | Hemodynamic vertebrobasilar insufficiency as an adverse effect of antihypertensive therapy | |
| WO2006125200A2 (en) | Method for reducing sepsis or cardiogenic shock associated with myocardial injury |